BIOMAT Database Logo BIOMAT Database Logo

[Studies on the fibrinolytic therapy in the patients with nephrotic syndrome (author's transl)]. 1980

M Shibata, and K Shimizu, and T Kishi, and K Kobayashi, and H Sakai, and H Sugiyama, and M Oguri

UI MeSH Term Description Entries
D007676 Kidney Failure, Chronic The end-stage of CHRONIC RENAL INSUFFICIENCY. It is characterized by the severe irreversible kidney damage (as measured by the level of PROTEINURIA) and the reduction in GLOMERULAR FILTRATION RATE to less than 15 ml per min (Kidney Foundation: Kidney Disease Outcome Quality Initiative, 2002). These patients generally require HEMODIALYSIS or KIDNEY TRANSPLANTATION. ESRD,End-Stage Renal Disease,Renal Disease, End-Stage,Renal Failure, Chronic,Renal Failure, End-Stage,Chronic Kidney Failure,End-Stage Kidney Disease,Chronic Renal Failure,Disease, End-Stage Kidney,Disease, End-Stage Renal,End Stage Kidney Disease,End Stage Renal Disease,End-Stage Renal Failure,Kidney Disease, End-Stage,Renal Disease, End Stage,Renal Failure, End Stage
D008875 Middle Aged An adult aged 45 - 64 years. Middle Age
D009404 Nephrotic Syndrome A condition characterized by severe PROTEINURIA, greater than 3.5 g/day in an average adult. The substantial loss of protein in the urine results in complications such as HYPOPROTEINEMIA; generalized EDEMA; HYPERTENSION; and HYPERLIPIDEMIAS. Diseases associated with nephrotic syndrome generally cause chronic kidney dysfunction. Childhood Idiopathic Nephrotic Syndrome,Frequently Relapsing Nephrotic Syndrome,Multi-Drug Resistant Nephrotic Syndrome,Pediatric Idiopathic Nephrotic Syndrome,Steroid-Dependent Nephrotic Syndrome,Steroid-Resistant Nephrotic Syndrome,Steroid-Sensitive Nephrotic Syndrome,Multi Drug Resistant Nephrotic Syndrome,Nephrotic Syndrome, Steroid-Dependent,Nephrotic Syndrome, Steroid-Resistant,Nephrotic Syndrome, Steroid-Sensitive,Nephrotic Syndromes,Steroid Dependent Nephrotic Syndrome,Steroid Resistant Nephrotic Syndrome,Steroid Sensitive Nephrotic Syndrome,Steroid-Dependent Nephrotic Syndromes,Steroid-Resistant Nephrotic Syndromes,Steroid-Sensitive Nephrotic Syndromes,Syndrome, Nephrotic,Syndrome, Steroid-Sensitive Nephrotic
D005260 Female Females
D005341 Fibrinolysin A product of the lysis of plasminogen (profibrinolysin) by PLASMINOGEN activators. It is composed of two polypeptide chains, light (B) and heavy (A), with a molecular weight of 75,000. It is the major proteolytic enzyme involved in blood clot retraction or the lysis of fibrin and quickly inactivated by antiplasmins. Plasmin,Fibrogammin,Glu-Plasmin,Protease F,Thrombolysin,Glu Plasmin
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D000293 Adolescent A person 13 to 18 years of age. Adolescence,Youth,Adolescents,Adolescents, Female,Adolescents, Male,Teenagers,Teens,Adolescent, Female,Adolescent, Male,Female Adolescent,Female Adolescents,Male Adolescent,Male Adolescents,Teen,Teenager,Youths
D000328 Adult A person having attained full growth or maturity. Adults are of 19 through 44 years of age. For a person between 19 and 24 years of age, YOUNG ADULT is available. Adults
D000368 Aged A person 65 years of age or older. For a person older than 79 years, AGED, 80 AND OVER is available. Elderly
D000818 Animals Unicellular or multicellular, heterotrophic organisms, that have sensation and the power of voluntary movement. Under the older five kingdom paradigm, Animalia was one of the kingdoms. Under the modern three domain model, Animalia represents one of the many groups in the domain EUKARYOTA. Animal,Metazoa,Animalia

Related Publications

M Shibata, and K Shimizu, and T Kishi, and K Kobayashi, and H Sakai, and H Sugiyama, and M Oguri
[Dipyridamole therapy in the nephrotic syndrome (author's transl)].
March 1978, Nihon Jinzo Gakkai shi,
M Shibata, and K Shimizu, and T Kishi, and K Kobayashi, and H Sakai, and H Sugiyama, and M Oguri
[Studies on the role of IgE in nephrotic syndrome (author's transl)].
September 1979, Nihon Jinzo Gakkai shi,
M Shibata, and K Shimizu, and T Kishi, and K Kobayashi, and H Sakai, and H Sugiyama, and M Oguri
[Indication and limitation of steroid therapy in patients with nephrotic syndrome (author's transl)].
October 1979, Horumon to rinsho. Clinical endocrinology,
M Shibata, and K Shimizu, and T Kishi, and K Kobayashi, and H Sakai, and H Sugiyama, and M Oguri
[Studies on the fibrinolytic therapy in patients with various renal diseases. Clinical effects of urokinase (author's transl)].
September 1981, Nihon Jinzo Gakkai shi,
M Shibata, and K Shimizu, and T Kishi, and K Kobayashi, and H Sakai, and H Sugiyama, and M Oguri
[Fibrinolytic system in patients with nephrotic syndrome].
January 1976, Terapevticheskii arkhiv,
M Shibata, and K Shimizu, and T Kishi, and K Kobayashi, and H Sakai, and H Sugiyama, and M Oguri
[Anticoagulant therapy in combination with pulse therapy--about 12 nephritic patients with nephrotic syndrome-- (author's transl)].
August 1980, Nihon Jinzo Gakkai shi,
M Shibata, and K Shimizu, and T Kishi, and K Kobayashi, and H Sakai, and H Sugiyama, and M Oguri
[Differentiated therapy of nephrotic syndrome in childhood (author's transl)].
August 1974, Monatsschrift fur Kinderheilkunde,
M Shibata, and K Shimizu, and T Kishi, and K Kobayashi, and H Sakai, and H Sugiyama, and M Oguri
[Paraneoplastic nephrotic syndrome (author's transl)].
March 1974, Deutsche medizinische Wochenschrift (1946),
M Shibata, and K Shimizu, and T Kishi, and K Kobayashi, and H Sakai, and H Sugiyama, and M Oguri
[Studies on fibrinolytic agent-platelet interaction (author's transl)].
April 1974, Nihon Ketsueki Gakkai zasshi : journal of Japan Haematological Society,
M Shibata, and K Shimizu, and T Kishi, and K Kobayashi, and H Sakai, and H Sugiyama, and M Oguri
[The shock-syndrome: aspects of coagulation and fibrinolytic therapy (author's transl)].
March 1974, Monatsschrift fur Kinderheilkunde,
Copied contents to your clipboard!